Profile data is unavailable for this security.
About the company
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
- Revenue in USD (TTM)0.00
- Net income in USD-88.50m
- Incorporated2021
- Employees68.00
- LocationIO Biotech IncOle Maaloes Veh 3COPENHAGEN 2200DenmarkDNK
- Websitehttps://www.iobiotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Benitec Biopharma Inc | 7.00k | -21.69m | 88.71m | 18.00 | -- | 2.24 | -- | 12,672.87 | -9.87 | -9.87 | 0.0031 | 4.22 | 0.0006 | -- | 0.1284 | 388.89 | -186.85 | -83.43 | -260.89 | -98.77 | 1,542.86 | 96.86 | -309,885.70 | -468.04 | -- | -307.03 | 0.00 | -- | 2.74 | -53.84 | -7.44 | -- | -56.51 | -- |
| Annovis Bio Inc | 0.00 | -56.20m | 89.71m | 6.00 | -- | -- | -- | -- | -6.12 | -6.12 | 0.00 | -0.7368 | 0.00 | -- | -- | 0.00 | -243.15 | -106.31 | -328.17 | -124.71 | -- | -- | -- | -- | -- | -4.03 | -- | -- | -- | -- | -121.90 | -- | -- | -- |
| SCYNEXIS Inc | 140.39m | 101.33m | 91.05m | 29.00 | 1.20 | 1.23 | -- | 0.6486 | 2.01 | 2.01 | 2.89 | 1.96 | 1.49 | -- | 136.30 | 4,840,862.00 | 107.48 | -30.02 | 175.37 | -36.35 | 88.97 | -- | 72.18 | -86.76 | -- | 193.81 | 0.1433 | -- | 2,652.72 | 252.64 | 206.74 | -- | -- | -- |
| LifeVantage Corp | 205.45m | 3.60m | 91.51m | 248.00 | 25.77 | 3.42 | 12.58 | 0.4454 | 0.2796 | 0.2796 | 16.01 | 2.11 | 3.20 | 2.53 | 91.56 | 828,443.60 | 5.60 | 11.65 | 8.51 | 18.92 | 79.32 | 82.20 | 1.75 | 3.42 | 1.01 | -- | 0.00 | 5.23 | 3.41 | 0.9838 | -18.59 | -18.77 | -7.98 | -- |
| IO Biotech Inc | 0.00 | -88.50m | 92.23m | 68.00 | -- | 0.7988 | -- | -- | -1.86 | -1.86 | 0.00 | 1.75 | 0.00 | -- | -- | 0.00 | -66.79 | -- | -72.66 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -20.47 | -- | -- | -- |
| Zhong Yuan Bio-Technology Holdings Ltd | 2.49m | 232.02k | 92.82m | 35.00 | 411.76 | 366.59 | -- | 37.22 | 0.0128 | -0.0176 | 0.1395 | 0.0143 | 0.8583 | -1.61 | 3.25 | 71,253.43 | 6.49 | -- | 19.10 | -- | 106.30 | -- | 7.57 | -- | 0.8309 | 2.53 | 0.8593 | -- | -28.60 | -- | -148.37 | -- | -- | -- |
| Anixa Biosciences Inc | 210.00k | -10.74m | 92.83m | 4.00 | -- | 3.76 | -- | 442.04 | -0.3451 | -0.3451 | 0.0068 | 0.7749 | 0.0078 | -- | 0.7807 | 52,500.00 | -40.49 | -59.69 | -41.26 | -62.61 | -- | -- | -5,174.29 | -6,040.10 | -- | -- | 0.00 | -- | -- | -28.36 | 27.83 | -- | -- | -- |
| Milestone Pharmaceuticals Inc | 0.00 | -55.09m | 93.01m | 47.00 | -- | 2.33 | -- | -- | -1.25 | -1.25 | 0.00 | 0.7498 | 0.00 | -- | -- | 0.00 | -53.21 | -48.44 | -56.51 | -51.56 | -- | -- | -- | -1,267.25 | -- | -- | 0.5592 | -- | -80.00 | -- | -2.22 | -- | 86.23 | -- |
| Eton Pharmaceuticals Inc | 34.30m | 913.00k | 93.76m | 30.00 | 107.89 | 6.05 | 50.60 | 2.73 | 0.0338 | 0.0338 | 1.33 | 0.6031 | 1.25 | 8.41 | 9.64 | 1,143,467.00 | 3.34 | -46.22 | 5.72 | -58.20 | 66.24 | 72.16 | 2.66 | -76.86 | 1.43 | -- | 0.2447 | -- | 48.90 | -- | 89.62 | -- | 26.85 | -- |
| Nanopharmaceutics Inc | 1.01m | -549.47k | 93.95m | 50.00 | -- | -- | -- | 93.06 | -0.0034 | -0.0034 | 0.0062 | -0.0508 | -- | -- | -- | 20,191.00 | -- | -- | -- | -- | 60.28 | -- | -110.51 | -- | 0.0417 | -433.32 | -- | -- | 0.3272 | -- | -39.70 | -- | -- | -- |
| Oramed Pharmaceuticals, Inc. | 674.00k | 10.46m | 94.41m | 15.00 | 9.37 | 0.5666 | 9.04 | 140.07 | 0.2488 | 0.2488 | 0.0165 | 4.11 | 0.0037 | -- | -- | 44,933.33 | 5.63 | -- | 6.27 | -- | -- | -- | 1,518.25 | -- | -- | -- | 0.162 | -- | -50.43 | -- | 115.11 | -- | -- | -- |
| Connect Biopharma Holdings Ltd (ADR) | 0.00 | -59.50m | 94.78m | 81.00 | -- | 0.9789 | -- | -- | -1.08 | -1.08 | 0.00 | 1.76 | -- | -- | -- | 0.00 | -- | -66.24 | -- | -71.36 | -- | -- | -- | -- | -- | -- | 0.0046 | -- | -- | -- | 49.61 | -- | 10.32 | -- |
| Armata Pharmaceuticals Inc | 4.70m | -79.58m | 95.81m | 66.00 | -- | -- | -- | 20.39 | -2.20 | -2.20 | 0.1302 | -1.56 | 0.041 | -- | 3.16 | 71,196.97 | -69.46 | -59.78 | -235.17 | -72.70 | -- | -- | -1,693.47 | -1,113.72 | -- | -1.11 | 1.75 | -- | -17.77 | -- | -87.03 | -- | 184.10 | -- |
| Angion Biomedica Corp | 0.00 | -35.19m | 95.97m | 32.00 | -- | 7.92 | -- | -- | -8.81 | -8.81 | 0.00 | 1.18 | 0.00 | -- | -- | 0.00 | -88.05 | -105.91 | -110.32 | -331.69 | -- | -- | -- | -712.81 | -- | -700.88 | 0.00 | -- | -100.00 | -- | 9.31 | -- | -- | -- |
Data as of May 17 2024. Currency figures normalised to IO Biotech Inc's reporting currency: US Dollar USD
46.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lundbeckfond Invest A/Sas of 09 Aug 2023 | 13.95m | 21.18% |
| HBM Partners AG (Investment Management)as of 31 Dec 2023 | 3.94m | 5.99% |
| PFM Health Sciences LPas of 31 Dec 2023 | 2.34m | 3.55% |
| Marshall Wace LLPas of 31 Dec 2023 | 2.11m | 3.20% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 2.08m | 3.15% |
| Armistice Capital LLCas of 31 Dec 2023 | 1.92m | 2.92% |
| Stonepine Capital Management LLCas of 31 Dec 2023 | 1.67m | 2.53% |
| BofA Securities, Inc.as of 31 Dec 2023 | 1.65m | 2.51% |
| Logos Global Management LPas of 31 Dec 2023 | 493.83k | 0.75% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 205.66k | 0.31% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
